Mustang Bio Ownership | Who Owns Mustang Bio?
Mustang Bio Ownership Summary
Mustang Bio is owned by 1.07% institutional investors, 10.94% insiders, and 87.99% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.59% of its assets in Mustang Bio shares.
MBIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Mustang Bio | 1.07% | 10.94% | 87.99% |
| Sector | Healthcare Stocks | 488.30% | 11.08% | -399.38% |
| Industry | Biotech Stocks | 307.10% | 11.11% | -218.21% |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 28 | 16.67% | 4,670,658 | 431.17% | 1 | 2625.66% | 16 | 77.78% | 2 | -50.00% |
| Sep 30, 2024 | 24 | -11.11% | 879,309 | 11.85% | - | 618.30% | 9 | -43.75% | 4 | -33.33% |
| Jun 30, 2024 | 27 | -3.57% | 786,144 | 5.70% | - | 1035.33% | 16 | 33.33% | 6 | -33.33% |
| Mar 31, 2024 | 28 | 7.69% | 743,734 | -28.01% | - | 263.19% | 12 | 33.33% | 9 | 80.00% |
| Dec 31, 2023 | 26 | 4.00% | 1,033,147 | 74.28% | - | 1064.51% | 9 | 50.00% | 5 | -28.57% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Institutional Extnd Mkt Idx Tr | 25.70K | 0.59% | 24.24K |
| Fidelity Extended Market Index | 18.94K | 0.26% | 7.17K |
| Antecedo Defensive Growth I | 46.67K | 0.07% | - |
| Fidelity Series Total Market Index | 2.88K | 0.04% | - |
| Spartan Total Market Index Pool G | 2.08K | 0.03% | 1.73K |
| BlackRock Extended Equity Market K | 12.09K | 0.03% | -5.00 |
| Delaware Healthcare I | 8.00K | 0.02% | - |
| Fidelity Total Market Index | 1.08K | 0.01% | - |
| NT Ext Eq Mkt Indx Fd DC Lend T4 | 2.81K | 0.01% | 2.81K |
| NT Ext Eq Mkt Indx Fd DC Lend T3 | 2.81K | 0.01% | 2.81K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 18, 2022 | Litchman Manuel MD | - | Buy | $3.69K |
| Sep 13, 2022 | Litchman Manuel MD | - | Buy | $2.58K |
| Sep 13, 2022 | ROSENWALD LINDSAY A MD | - | Buy | $2.58K |
| Mar 18, 2022 | ROSENWALD LINDSAY A MD | - | Buy | $3.03K |
| Dec 14, 2021 | Achenbach Brian | SVP, Fin. & Corp. Controller | Sell | $8.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q2 | - | - |
MBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools